home / stock / avcnf / avcnf articles

AVCNF Articles, Avicanna Inc

Stock Information
Company Name: Avicanna Inc
Stock Symbol: AVCNF
Market: OTC
Website: avicanna.com
Menu
AVCNF AVCNF Quote AVCNF Short AVCNF News AVCNF Articles AVCNF Message Board
Get AVCNF Alerts

News, Short Squeeze, Breakout and More Instantly...
Latest Cannabis Hires And Board Changes, Here's What You Need To Know | Benzinga

As Benzinga Cannabis Capital Conference returns to Chicago this Oct. 8-9 for its 19th edition, gathering top CEOs, investors investors and leaders ...
Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country | Benzinga

Cannabinoid-focused biopharmaceutical company Avicanna Inc. (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN) announced on Thursday that it has completed the com...

Avicanna Announces Results of Annual General Meeting & Provides Corporate Update | Benzinga

TORONTO, July 10, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company") (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN) a biopharmaceutical c...

Avicanna Announces USPTO Issuance of Patent SEDDS Technology | Benzinga

TORONTO, June 19, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or "Company") (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN), a biopharmaceutical comp...
Avicanna to Present at the Life Science Investor Forum June 20th, 2024 | Benzinga

TORONTO, June 18, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or "Company) (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN) a biopharmaceutical compan...

CBD-Focused Avicanna Reports First-Ever Adjusted EBITDA Positive Quarter, 451% YoY Spike In Q1 Record Revenue | Benzinga

Cannabis-focused biopharmaceutical company Avicanna Inc. (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN) announced its financial results on Tuesday for the fir...

CBD Helps With This Rare Blistering Skin Disorder, New Study From Avicanna Shows Promising Results In Epidermolysis Bullosa Treatment | Benzinga

There is no cure for a rare blistering skin disorder called Epidermolysis Bullosa (EB), but treatments to help alleviate and control the symptoms d...
Avicanna Announces Closing of Non-brokered Private Placement | Benzinga

TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company") (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN) a biopharmaceutical ...

Cannabinoid-Based Products Maker Sees Triple-Digit Growth In 2023 Gross Profit, Revenue Surges 314% YoY | Benzinga

Avicanna Inc. (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN), the cannabinoids-focused biopharmaceutical company reported its year-end 2023 results and audite...

Avicanna Reports Full Year 2023 Audited Financial Results | Benzinga

$16.8M in Revenue, representing an increase of 314% from 2022$6.7M Consolidated gross Profit, representing an increase of 500% from 2022 TORONTO, ...
Next 10